Product Description
| Cat Number | PP-390 |
|---|---|
| Category | Peptide |
| Pack Size | 1 mg |
| Description | Blocks BRCA2-RAD51 interaction |
| Modification | N terminal acetyl, C terminal amide |
| Purity | >95% by hplc |
| Biomarker Target | Protein-protein interactions |
| Sequence Three Letter Code | Ac-Leu-Leu-Gly-Phe-His-Thr-Ala-Ser-Gly-Lys-Lys-Val-Lys-Ile-Ala-Lys-NH2 |
| Molecular Formula | C81H139N23O19 |
| Sl Sequence | Ac-LLGFHTASGKKVKIAK-NH2 |
| Solubility | Soluble in water |
| Appearance | Freeze dried sold |
| Storage | Store dry, frozen and in the dark |
| References |
Trenner et al (2018) A Short BRCA2-Derived Cell-Penetrating Peptide Targets RAD51 Function and Confers Hypersensitivity toward PARP Inhibition. Mol Cancer Ther. 17(7) 1392 PMID: 29654063 Related areasAll peptides >All protein-protein interaction modulators >All cancer research categories > |
| Note | The product is for research use only |
Share Item: